01 1Infliximab
02 1Telavancin
03 1infliximab
01 1SAMSUNG BIOLOGICS Co., Ltd.
02 2Samsung BioLogics Co. LTD
01 3South Korea
NDC Package Code : 71124-0004
Start Marketing Date : 2018-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71124-0031
Start Marketing Date : 2023-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71124-0005
Start Marketing Date : 2020-06-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (750mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
